Sep 24, 2024
The RESHAPE-HF2 (Randomized Investigation of the MitraClip Device in Heart Failure [HF]: Second Trial in Patients With Clinically Significant Functional Mitral Regurgitation [MR]) trial assessed the safety and efficacy of mitral transcatheter edge-to-edge repair (M-TEER) using MitraClip among symptomatic HF patients...
Sep 17, 2024
The goal of the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction...
Sep 10, 2024
It is imperative that clinicians understand the differences in each patient and how effective therapies must be individualized and often combined to treat patients with varying profiles. Efforts to unify heart failure across the ejection fraction and rebrand "heart failure" to "heart success" may be achieved by better...
Sep 3, 2024
In this interview, Vidhu Anand, MD, FACC, and Alison L. Bailey, MD, FACC, provide a comprehensive exploration of Low Flow-Low Gradient Aortic Stenosis, shedding light on its definition and exploring treatment approaches for patients with HF.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe...